September 8, 2010

OSTEOMYELITIS “DEATH MESSAGE” – HYPE? George Cierny, MD

Posted under: OSTEOMYELITIS TREATMENT, pathophysiology— George Cierny @ 9:23 pm

Apparently, there are Irish researchers proposing a protein-induced ”death message” to bone cells as the sinequanon of Staphylococcal virulence in causing osteomyelitis.   The authors are referring to Surface Protein-A (SPA), a well studied virulence factor known to bind immune-globulins(IgG), coat (hide) the staphylococcal cell from the host (like/like), prevent complement mediated cell lysis and block uptake/killing by inflammatory cells.  According to PubMed, the authors have not published a  peer reviewed journal article on the topic of osteoblast-binding proteins or the existence/isolation/sequencing of a “death message”to bone cells.   In the full scheme of things, it would seem hard to supersede the massive lysis of inflammatory cells and the 30+ toxins and superantigens these pathogens bring to the table.   According to Mark Shirtliff, PhD (Univ. Maryland), an expert on multifactorial proteins known to mediate bacterial virulence, there are plenty of articles referencing an osteomyelitis caused by Staphylococci proven SPA-protein deficient.    Reference – Baum C, Haslinger-Löffler B, Westh H, Boye K, Peters G, Neumann C, Kahl BC.  Non-spa-typeable clinical Staphylococcus aureus strains are naturally occurring protein A mutants.  J Clin Microbiol, 2009; 47(11):3624-9.  Epub 2009 Sep 16).     GC

August 24, 2010

My Osteomyelitis: Michelle’s story; George Cierny, MD

Michelle’s Osteomyelitis Story: from http://www.sharp.com/ortho/michelle-osteomyelitis-story.cfm

For most cancer patients, hearing the words “cancer free” signifies victory — the end of a long and painful battle. Unfortunately, that wasn’t the case for 62-year-old Michelle Ashwell.  In 2005, Michelle had a malignant tumor removed from her left leg, just above the knee. “I made it through the cancer, and at first, it seemed like everything was going to be OK,” she said. “However, the treatment that followed actually prevented my recovery from moving forward.”  The radiation therapy Michelle underwent after having the tumor removed set in motion a series of debilitating complications. The  Michelle-Ashwell_resizedradiation treatments, which were only intended for the soft tissues surrounding the tumor site, extended deeper into the bone. As a result, the tissue deep within her wound pulled away from the bone and would not heal. This complication required Michelle to undergo a second surgery, which was intended to repair and heal the wound.

Unfortunately, the second surgery did not produce the desired outcome; and on top of that, the wound became infected. Michelle had developed osteomyelitis, which is an infection of the bone or bone marrow. The infection prevented the open wound in her leg from healing and severely limited the motion in her knee.  “It was very discouraging,” said Michelle. “I went through many different kinds of surgeries and none of them helped.”

After being advised to consider amputation, and preparing herself for the possibility that this course of action was the only way to eliminate the infection, Michelle was referred to Sharp-affiliated orthopedic surgeons Drs. George Cierny and Doreen DiPasquale.

Following a preliminary consultation and exam, Dr. Cierny told Michelle he was confident that he could save her leg. “When I heard him say that, part of me was wondering if it was too good to be true.”  Subsequent surgeries performed under Dr. Cierny’s direction included placement of antibiotic-impregnated beads into the wound and stabilization of the upper leg bone via a bone-plate and screws to prevent fracture. Finally, a flap of living tissue from Michelle’s abdomen was transplanted onto the wound. Unlike previous surgeries in which a similar procedure had been performed, the new living flap was, this time, attached to blood vessels outside the area treated with radiation.  Following this multidisciplinary treatment plan and continuous physical therapy, Michelle emerged infection free in January 2008.  

She is especially grateful for the fact that she has since regained full motion in her knee.  “I love taking care of my one-year-old grandson, Brayden,” said Michelle. “He just started walking, and he’s fast!”  At the height of her medical complications, Michelle struggled to keep up with her favorite pastimes, which include gardening. Following recovery, she has been able to return to and even grow some of those activities. She recently relandscaped her entire backyard, a symbol of her personal growth and passion for life.  Today, Michelle remains cancer- and infection-free.

August 17, 2010

KEN’S OSTEOMYELITIS STORY: George Cierny, MD; www.sharp.com/ortho/ken-johnson-osteomyelitis-story.cfm

Ken’s Osteomyelitis Story: Osteomyelitis treatment at Sharp Memorial Hospital, San Diego, CA……What began as a nagging pain in Ken Johnson’s upper leg and buttocks region evolved into a long and painful battle that diminished his quality of life. Everyday activities, and even a trip to Italy, were plagued by chronic discomfort. Eventually, the pain escalated to the point that the seasoned financial advisor was unable to make it through a day on the job. Consequently, he had to miss nine consecutive months of work. 

 Ken_Johnson“It consumed my life,” said  Ken. “I didn’t think I would  ever get better. No one could  figure out what was going  on.”

 After initially being told that  arthritis was the culprit, Ken  was diagnosed with  osteomyelitis: a chronic inflammation of the bone or bone marrow. His entire hip was infected, and in April of 2008 he underwent surgery to have it removed. Unfortunately, removing the hip did not eliminate the problem; persistent infection, pain and impaired leg function remained and he began suffering from 100 to 102 degree fevers on a daily basis.

“To be sick every single day was exhausting. Nothing seemed to help.“ Ken regained a sense of hope after seeking treatment from Sharp-affiliated orthopedic surgeons Drs. George Cierny and Doreen DiPasquale.

“They evoke a sense of confidence, are very good at what they do and, after reading the first MRI, were able to see where the infection was hiding; deep within my pelvis bone,” said Ken.

Drs. Cierny and DiPasquale are among a handful of physicians worldwide who specialize in the treatment of orthopedic infections. Utilizing state-of-the-art diagnostics, they located the source of infection and performed the surgery necessary to save Ken’s leg at Sharp Memorial Hospital in July of 2008.

Ken says his wife knew the surgery was a success even before he woke up. “She noticed, even though I was asleep, that the pained look on my face was gone.”

In addition to removing the source of the infection, Drs. Cierny and DiPasquale restored Ken’s hip motion and leg length using an antibiotic infused prosthesis to treat the infection locally. After relying on crutches, a walker or wheelchair to get around for months, he was once again able to walk unassisted.

Three months later, once the infection had cleared up, Ken underwent a total hip replacement surgery at Sharp Memorial Hospital, which further escalated his recovery. “From that point on, I just got better and better,” he said. “I went back to work full-time at the end of January 2009.”

A year and a half after undergoing hip replacement surgery, Ken is not only back at work — he has reclaimed the quality of life he knows and loves. He’s back to golfing, riding motorcycles and playing the drums. He remains infection-free.

June 26, 2010

OSTEOMYELITIS – Diagnostic, Radiographic Imaging; George Cierny, MD

Posted under: Diagnosis: Nuclear Scans, Diagnosis: testing— George Cierny @ 12:41 pm

Commentary:    The diagnostic imaging of osteomyelitis (bone infection) can require the combination of diverse imaging techniques for an accurate diagnosis and clinical staging .(1)   Conventional radiography should always be the first imaging modality to start with, as it provides an overview of the anatomy and the pathologic conditions of the bone and soft tissues of the region of interest.  However, since the specificity of plain x-rays for detection is higher than its sensitivity, other, more reliable methods of imaging are necessary.(2 – 4)   Ultra-sonography is most useful in the diagnosis of fluid collections, periosteal involvement, and surrounding soft tissue abnormalities and may provide guidance for diagnostic or therapeutic aspiration, drainage and/or tissue biopsy. Computed tomography (CT) scans can be a useful method to detect early osseous erosion and to document the presence of sequestra, cloacae, foreign bodies, or gas formation; nevertheless, they are generally is less sensitive than other modalities for the detection of osteomyelitis.(3)   Magnetic resonance imaging (MRI) is the most sensitive and most specific imaging modality for the detection of infection in bone (Sens /Spec = 82%-100%/ 75%-95%), provides superb anatomic detail and gives more accurate information of the extent of the infectious process in bone and soft tissue.(3 -5)    Although nuclear medicine imaging (technetium-99 bone scans and Indium-111 white blood cell scans) is particularly sensitive in identifying multifocal osseous involvement, they are rather nonspecific.(6)   

Since no one study is able to definitively confirm the presence of absence of infection, cross-sectional imaging modalities such as CT and MR scanning are now considered the gold standard in diagnosing osteomyelitis, giving excellent anatomic delineation of the infected area and the surrounding soft tissue envelope.   In our protocols, all methods of used, selectively: (7) plain radiographs  to reveal internal hardware, axial alignment, fracture patterns and instability; nuclear scans  to correlate  cellular activity with radiographic change and assess for  poly-osseous disease;  CT scans to delineate sequestra, cloacae, bone volumes, and the extent of fracture healing (union vs non-union);  MRI and PET/CT scans to define the zone of injury/inflammation, disclose skip-lesions and highlight necrotic foci.   

Bibliography:  (1) Haas DW, McAndrew MP. Bacterial osteomyelitis in adults: evolving considerations in diagnosis and treatment. Am J Med, l996; 101:550-561.  (2)  Pineda C, Espinosa R, Pena A. Radiographic imaging in osteomyelitis: the role of plain radiography, computed tomography, ultrasonography, magnetic resonance imaging, and scintigraphy.   Semin Plast Surg, 2009 May; 23(2):80-9.  (3) Termaat MF, Raijmakers PG, Scholtein HJ et al. The accuracy of diagnostic imaging for the assessment of chronic osteomyelitis: a systemic review and meta-analysis. J Bone Joint Surg Am, 2005; 87:2464-2471.  (4) Mahnken AH, Bucker A, Adam G, Gunther RW. MRI of osteomyelitis: sensitivity and specificity of STIR sequences in comparison with contrast-enhanced T1 spin echo sequences. RöFo, 2000; 172” 1016-1019.  (5) Littenerg B, Mushlin AL. Technetium bone scanning in the diagnosis of osteomyelitis: a meta-analysis of test performance. J Gen Intern Med, l992; 7:158-163.  (6) Cierny III, G., Pennick, JJ, Mader, JT, A Clinical Staging System for Adult Osteomyelitis, J. Clinical Orthopaedics and Related Research, Number 414, pp 7-24, September 2003 .  (7)  Cierny G, DiPasquale D. Adult Osteomyelitis. Chapter 16 in Orthopaedic Knowledge Update : Musculoskeletal Infection. Amer. Acad. Orthop. Surg, Rosemont, IL, 2009. pp 135-155.

June 7, 2010

VERTEBRAL OSTEOMYELITIS: G. Cierny, MD; osteomyelitis BLOG

Posted under: Diagnosis: testing, Historical perspectives, Vertebral Osteomyelitis— George Cierny @ 8:45 pm

Article review:   Bhavan KP, Marschall J, Olsen MA, et al:  The Epidemiology of hematogenous vertebral osteomyelitis: a cohort study in a tertiary care hospital.  BMC Infectious Diseases, 2010: 10: 158doi: 10.1186/1471-2334-10-158  (Published 7-7-2010).

Dr. Cierny’s comments:  this article describes the epidemiology and early management of hematogenous vertebral osteomyelitis (anatomic types I and IV) in 70 patients over a 2-year period at Barnes Hospital in Missouri (a retrospective, cohort review).  A microbiological diagnosis was made in only two-thirds the cases.  S. aureus was the most common causative organism.

Results – The mean age was 59.7 years with 54% male. Predisposing factors included: B-hosts with diabetes (43%) or renal insufficiency (24%); in the 30 days prior to admission, an indwelling catheter (30%), bacteremia (19%) or skin/soft tissue infection (17%).  Back pain was the most common symptom (87%), followed by weakness (56%) and fever (46%); seven patients presented with paraplegia.  48% had a normal WBC but 95-98% had either an elevated ESR or CRP

The lumbar spine was the most common anatomic location (47%): thoracic (29%); cervical (24%).  Among the 46 (66%) patients with a microbiological diagnosis, the most common organisms were MSSA (33%) and MRSA (22%).  Among the 44 (63%) patients who had a diagnostic biopsy, open biopsy was more likely to result in pathogen recovery [14 (93%) of 15 with open biopsy vs. 14 (48%) of 29 with needle biopsy; p=0.003].   Surgery was required during the initial hospitalization in 23% of patients: decompression laminectomy 14%), laminectomy /fusion (7%) and corporectomy (1%).  Treatment outcomes were not included.  

April 22, 2010

Eric Wickre’s Hoka Hey Motorcycle Challenge

Meet Eric Wickre (the original, Alaskan Viking Cowboy), treated at our center December 2008 for Stage IA osteomyelitis of his left tibia, a con-sequence of an open fracture suffered in 1981.   His (and others’) entire medical case portfolio will be posted  at http://www.osteomyelitis.com/html/news.html#featured-case .  After successful treatment at our treatment center in  San Diego, Eric is now back to his rough-and-ready cowboy ways, having just been selected to be one of 1000 motorcyclists from around the globe to compete in The Hoka Hey Motorcycle Challenge —– also known as the “Iditarod of Harley Davidson, 2010”.

 CLICK TO ENLARGE

CLICK TO ENLARGE

The Challenge is a grueling, 7,000 mile race from Key West, FL to the Kenai Peninsula, Alaska where “winner takes all” …one half million dollarsin Alaskan gold!  It starts June 20th and ends in Homer, AK on July 4th.  The secret route will initially head 1,000 miles into Mississippi. There, riders will get a map for the next leg of the ride: traveling the back roads, highways and byways; enduring hail storms, heat waves and scorpions; sleeping along side their bikes every night for the entire journey.

Join us as we follow Eric’s epic journey through the Americas on  OSTEOMYELITIS  BLOG.                                           Good luck, Eric!!

BONE INFECTION: treatment(types of surgery)

George Cierny, MD; REOrthopaedics in San Diego

In acute pediatric osteomyelitis  and osteomyelitis of the spine (verbetral osteomyelitis; sacroiliitis) in all ages,  surgery is not always necessary to affect cure.  In other forms of acute osteomyelitis  (infection following open fracture; surgical site infections following trauma or reconstructive surgery) and nearly all forms of the chronic disease, treatment will have to combine various aspects of surgery (with antibiotics) to result in cure .
The treatment of a refractory (chronic) osteomyelitis is governed by its pathophysiolgy —– it is a ‘biofilm disease’.    Unlike the mobile (planktonic), environmentally sensitive microbes found in an acute infection, chronic wound pathogens are sessile and resilient, transformed into colony-forming units by environmental triggers (quorum-sensing) and the successful attachment to ‘unprotected’ surfaces within the wound (inert materials; non-viable tissues or organisms, etc.).    Thereafter, individual cells become colony-forming units that mature (2-4 weeks) to secrete and maintain a mucopolysaccharide “slime” that protects them from host defenses and the penetration of most antimicrobial agents .   To cure this biofilm infection, a LIVE, CLEAN WOUND is paramount: the biofilm-colony its attachment surfaces must be completely excised.

The type of surgery will depend on the duration of the infection (acute or chronic), the contents of the wound (extent of necrosis; substrate surfaces), the anatomic site, the health and well-being (impairment) of the host, and the experience of the healthcare team.

However, surgery, as a form of treatment, is not available to everyone. Patients who are very ill may not be able to endure the extensive surgery and recovery. In these cases, doctors may use antibiotics for long periods in an attempt to suppress (rather than cure) the infection.  Then, if the infection persists and, again, threatens the patient’s well-being, lesser morbid procedures, such as amputation of all or part of an infected limb, may be necessary.  

Surgical treatment options  – Drain the infected area: Opening up the area around the infected bone allows the surgeon to drain any pus or fluid that has accumulated in response to the infection.  This is usually applied in the acute setting to decrease strain on host defenses and amplify the effects of antibiotics.  Remove the attached, biofilm-colony:  In a procedure called debridement, the surgeon removes the diseased bone and tissue. In some cases, foreign objects, such as surgical plates or screws, used in previous surgeries, may also be removed. Restore the bone and soft-tissue envelope: Your surgeon may fill any empty space left by the debridement procedure with a piece of bone or other tissue, such as skin or muscle, from another part of your body. Sometimes temporary fillers containing antibiotics (antibiotic depots) are placed in the space until the infection is cured and the patient is healthy enough to undergo a definitive reconstruction. Bone grafts and tissue flaps help the body recruit new blood vessels into the site and form new bone.  Protect against instability: Immediately following debridement, the surgeon may use an external fixatation device (external fixator) to hold and protect the bone from further injury.  This method limits the amount of implanted, foreign material (metal) in the still-contaminated wound by attaching thin wires or pins (that pass through the limb) to a frame positioned around the limb (outside the skin).  The fixator can be the only method used throughout treatment or, after a course of local antibiotic therapy, replaced with internal methods of fixation such as metal plates, rods or screws.

April 19, 2010

PREVENTING HOSPITAL-ACQUIRED INFECTIONS

Posted under: Diagnosis: testing, Surgical site Infections— George Cierny @ 8:24 am

PREVENTING HOSPITAL ACQUIRED INFECTIONS:   The translation of basic epidemiologic evidence into successful prevention has led to several successes in hospital-acquired infection prevention research over the past decade.  First is the use of alcohol-based hand rubs in clinical practice.

I.  Hand Hygiene:  Before the past decade, the major method of decontamination of the hands was the use of soap and water. The limitations of this procedure included the time it took to do, the number of sinks and the location of sinks in the hospital defined the optimal adherence to policy, and repeat use of detergents can be very irritating to the skin.

In 2002, the Centers for Disease Control and Prevention [CDC] through the Healthcare and Infection Control Practices Advisory Committee firmly established alcohol-based hand rubs at the center of hand hygiene practices, recommending them for routine decontamination of hands in all clinical situations except when the hands are visibly soiled.    Application of the rub takes seconds, the compounds are non-irritating and the dispensers are small, inexpensive and accessible wherever needed.  By 2008 84% of all US hospitals surveyed indicated that they had adopted alcohol-based hand rub and number of studies have shown dramatic increases in adherence to hand hygiene.  - Mody L, et al; Adoption of Alcohol-Based Handrub by United States Hospitals: a National Survey. Infect Control Hosp Epidemiol., 2008; 29:1177-1180.

 

II. Central Line catheter infections:  In the 2000s, there were 2 separate reports of large collaborative regional demonstration projects that focused on improved implementation of existing recommendations to prevent central line-associated blood stream infections (CLABSI) among patients in intensive care units (ICUs), first in southwestern Pennsylvania (2005) and then in Michigan (2006). Both studies demonstrated ~70% reductions in CLABSI rates across a wide variety of facility and ICU types, suggesting that the preventable fraction of these infections was perhaps much larger than we had originally thought.  The protocol was a 5-step process:  1) hand hygiene by the person inserting the device.  2) maximal barrier precautions.  3) chlorhexidine gluconate for antisepsis applied to the site of the insertion.  4) avoidance of femoral central line insertion.  5) removal of the central line as soon as possible /when no longer needed.

The results of these 2 studies have changed expectations of CLABSI prevention programs. The earlier single-center reports were viewed by many as somehow aberrant, the result of special circumstances and/or resources that could exist only in those particular, reporting facilities. These regional studies demonstrated that better implementation of existing recommendations can have a major impact across a wide spectrum of hospital settings —– dramatic success was possible, and not just under special circumstances.

III. DECOLONIZATION OF PATIENTS: Another innovative advance is the role of “source control” in preventing infection, particularly with the use of chlorhexidine bathing of patients. Based on data suggesting that colonization of a patient’s skin is an important source of spread for epidemiologic imported bacteria, it was hypothesized that daily bathing with a skin antiseptic (chlorhexidine gluconate) would decrease the burden of the patient’s skin contamination, indirectly decrease contamination in the environment, decrease transmission by healthcare worker, and play a role in decreased transmission of resistant pathogens and the incidence of both surgical site infections and CLABSI.  Today, data strongly suggest that daily chlorhexidine bathing can significantly reduce contamination of the patient’s skin, the environment, and healthcare workers’ hands, and an impact on methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE) acquisition has been documented.  - Barta R, Cooper BS, Whitely C, Patel AK, Wyncoll D, Edgeworth JD.  Efficacy and limitation of a chlorhexidine-based decolonization strategy in preventing transmission of methicillin-resistant Staphylococcus aureus in an intensive care unit. Clin Infect Dis. 2010;50:210-217.

Discussion: One area of controversy is the role of active surveillance, or what the value is of actively screening patients for MRSA.  . Most of the studies done in the past were typically small, single-institution studies, and often with quasi-experimental, pre- vs post- design. The results from those studies leave the conclusions open to interpretation and raise the issues of potential confounding or bias. With that said, even more rigorously done, recent studies have come to different conclusions.   Clearly, more work needs to be done.  - Harbarth S, Fankhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA. 2008;299:1149-1157. CONCLUSION: A universal, rapid MRSA admission screening strategy did not reduce nosocomial MRSA infection in a surgical department with endemic MRSA prevalence but relatively low rates of MRSA infection.Robicsek A, Beaumont JL, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med. 2008;148:409-418.  CONCLUSION: The introduction of universal admission surveillance for MRSA was associated with a large reduction in MRSA disease during admission and 30 days after discharge.

IV. Catheter-Associated Urinary Tract Infections:  Wald and colleagues  looked at catheter-associated UTIs [urinary tract infections] — morbidity and mortality associated with the device.  There is good evidence that getting the catheter out by postoperative day 2 makes a real difference. – Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg. 2008;143:551-557.

February 28, 2010

ARE YOU AT INCREASED RISK FOR A BONE INFECTION? George Cierny, MD, and Doreen DiPasquale, MD

IF YOU HAVE DIABETES, A JOINT REPLACEMENT OR ARTHRITIS…. YOU’RE AT INCREASED  RISK FOR A BONE INFECTION?  George Cierny, MD, and Doreen DiPasquale, MD; *BottomLine Health, 2010; Vol 24(3), pp9-11

* Bottom Line/Health interviewed George Cierny, MD, and Doreen DiPasquale, MD, physician-partners at REOrthopaedics in San Diego.  Dr. Cierny is an international lecturer in orthopedic surgery who has published more than 100 scien­tific papers and/or book chapters in the field of musculoskeletal pathology and infection. Dr.Di­Pasquale, an orthopedic-trauma surgeon, is former resi­dency program director at George Washington University in Washington, DC, and National Na­val Medical Center in Bethesda, Maryland.

—————- When most people think of bone problems, broken bones and osteoporosis (re­duced bone density and strength) come to mind. But our bones also can be the site of infections that can sometimes go unrecognized for months or even years. This is especially the case if the only symptoms of bone infection (a condition known as osteo­myelitis) are ones that are commonly mis­taken for common health problems, such as ordinary back pain or fa­tigue. What you need to know…

ARE YOU AT RISK? Older adults (age 70 and older), people with diabetes or arthritis and anyone with a weakened immune sys­tem (due to chronic disease, such as cancer, for example) are among those at greatest risk for osteo­myelitis.   Anyone who has an artificial joint (such as a total hip replacement or total knee replacement) or metal implants attached to a bone also is at increased risk for osteomyelitis and should discuss the use of anti­biotics before any type of surgery, including routine dental and oral surgery. Bacteria in the mouth can enter the bloodstream and cause a bone infection.

TYPES OF BONE INFECTIONS: Before the advent of joint-­replacement surgery, most bone in­fections were caused by injuries that expose the bone to bacteria in the en­vironment (such as those caused by a car accident) or a broken bone…or an infection elsewhere in the body, such as pneumonia or a urinary tract infection, that spreads to the bone through the bloodstream. Now: About half the cases of osteo­myelitis are complications of surgery in which large metal implants are used to stabilize or replace bones and joints (such as in the hip or knee).   

Osteomyelitis is divided into three main categories, depending on the origin of the infection… Blood-born osteomyelitis occurs when bacteria that originate else­where in the body migrate to and in­fect bone. People with osteoarthritis or rheumatoid arthritis are prone to blood-borne infections in their af­fected joints due to injury to cells in the lining of the joints that normally prevent bacteria from entering the bloodstream. Contiguous-focus osteomyelitis oc­curs when organisms— usually bacte­ria, but at times fungal species —infect bone tissue. These cases usually occur in people with diabetes, who will often de­velop pressure sores on the soles of their feet or ­buttocks due to poor cir­culation and impaired immunity.   Post-traumatic osteomyelitis: Trau­ma or surgery to a bone and/or sur­rounding tissue can open the area to bacteria and other microbes. The use of prosthetic joints, surgical screws, pins or plates also makes it easier for bacteria to enter and in­fect the bone.  Important: any of the three types of bone infections described above can lead to chronic osteomyelitis, an initially low-grade infection that can persist for months or even years with few or no symptoms. Eventu­ally it gets severe enough to liter­ally destroy bone. Left untreated, the affected bone may have to be amputated.

DIFFICULT TO DIAGNOSE – When osteomyelitis first develops (acute osteomyelitis), the symptoms —such as pain, swelling and tender­ness—are usually the same as those caused by other infections. If the initial infection is subtle (low-grade) or doesn’t resolve completely with treatment, it can result in chronic osteomyelitis. In this case, you may have no symptoms or symp-toms that are not specific.  For example, some one who has had surgery might blame discomfort on delayed recovery, not realizing what they have a bone infection.  A surprising finding: When we stud­ied the histories of more than 2,000 osteomyelitis patients, we found that most of those with chronic infections had relatively little pain from the in­fection itself. About 28% of those who required surgery for infection had normal white blood cell counts—suggesting that, over time, the body adjusts to lingering infections.  If a doctor suspects that you may have osteomyelitis because of chron­ic pain…swelling…possibly fever…fatigue…or other symptoms, he/she will usually order special laboratory tests that detect the formation of an­tibodies and/or cellular signaling compounds. If the results indicate the presence of infection, he/she may then order an X-ray, a magnetic reso­nance imaging (MRI) scan or a nuclear scan(bone scan). These and other imaging tests can readily detect damaged­ bone tissue and re­veal the presence of infection.

BEST TREATMENT OPTIONS   About 60% to 70% of people with acute osteomyelitis can be cured with antibiotics (or anti­fungal agents, if a fungal infection is present) if treat­ment begins early enough to prevent the infection from becoming chronic. In these cases, patients exhibit symp­toms…test positive for infection…and readily respond to drug treatments. Most patients can be cured with a four- to six-week course of antibiotics. Fungal infections are more resistant to treatment—antifungal drugs may be needed for several months.

For chronic osteomyelitis, surgical debridement (the removal of dam­aged tissue and bone using such in­struments as a scalpel, dental burrs and/or chisels) usually is necessary. Reasons: dam­aged bone can lose its blood supply, die and remain in the body without living cells or circu­lation. Such “dead bone” is invulnerable to the effects of antibiotics and provides safe haven to organisms attached to its surface.  To address this, the surgeon, after debridement, may insert a slow-release antibiotic depot (antibiotic beads) that release antibiotic for up to a month. This approach can increase drug concentrations up to 100 times more than oral antibiotic therapy and help to eliminate the sequestered microorganisms.   Using these and other innovations, the REOrthopaedics  center in Southern California now posts an overall success rate of 95%.    Nevertheless,  up to 6% of patients who are otherwise healthy may require a second or even a third operation to completely cure the infec­tion;  and, iIn patients suffering from diabetes or oth­er disorders affecting wound healing (compromised hosts) , the percentage may be as high as 25%.    To improve your chances of a full recovery from chronic osteomyeli­tis following treatment: eat well, maintain healthy blood sugar levels, stay active after treat­ment (to promote blood circulation, prevent blood clots and help main­tain an appetite) and don’t use to­bacco products.

Copyright © 2009 by Boardroom Inc., 281 Tresser Blvd., Stamford, Connecticut 06901-3229.                          www.BottomLineSecrets.com

February 16, 2010

WHAT IS and WHAT CAUSES OSTEOMYELITIS? Dr. Cierny comments on the recent article in Medical News Today: 10 Feb 2010-0:00PST

The article:  What is Osteomyelomyelitis? What Causes Osteomyelitis?” in Medical News Today: 10 Feb 2010-0:00PST

Dr. Cierny comments:

TYPES OF OSTEOMYELITIS: ‘Acute’,’ sub-acute’ and ‘chronic’ are time-related terms that parallel the fundamental principles and mechanisms  inherent to wound colonization by microorganisms.  Early in the course of infection, microorganisms are mobile (plankonic) and vulnerable to antibiotics and host defenses.   If the fracture is live and stable, the infection may resolve following adequate wound decompression, antimicrobials and the elimination of dead space (the acute wound).  After 2-3 weeks,  reactions between surface macromolecules begin forming at pathogen-substrate interfaces (sub-acute), resulting in a resilient “microzone’ of attachment in 4-6weeks that is precursor to a microbial-based, mucopolysaccharide “slime” that encompasses the entire colony.   Within the bio-slime (biofilm) microbial nutrition and growth are enhanced, protected from host defenses and the penetration /effects of antimicrobials.  The result is a profound compromise to the host: wound healing and fracture repair are impaired due to toxins produced by the pathogens and the by-products of host efforts to unsuccessfully destroy the biofilm colony. Curative treatment of such a biofilm-infection (chronic /refractory) requires both anti-microbial therapy and surgical removal of the entire biofilm burden.

WHAT ARE THE SIGNS AND SYMPTOMS OF OSTEOMYELITIS? See: http://www.osteomyelitis.com/html/osteomyelitis.html

WHAT ARE THE RISK FACTORS FOR OSTEOMYELITIS? Open fractures create “the perfect storm” for infection to complicate injury:  the initial wound is contaminated and injury to soft tissues potentiates an on going exposure to pathogens; surgical implants and dead bone fragments grant ‘safe-haven’ to proliferating microbes; ischemia, dead space and foreign bodies impede local immunity and the delivery of antibiotics; shock, injury and pre-existing health conditions compromise the host response.   The goals of treatment are three-fold: timely intervention; creation/maintenance of a clean, manageable wound; adequate and durable fracture fixation.

Surgical Site Infections (infection following elective surgery) are more common in compromised hosts,( ), long procedures (SSI) and operations where in a large surgical implant is used (substrat surfaces; see above).  OSTEOMYELITIS: CIERNY/MADER HOST STATUS  OSTEOMYELITIS: CIERNY/MADER CLASSIFICATION SYSTEM 

DIAGNOSIS OF OSTEOMYELITIS:   MALNUTRITION;   WHAT BLOOD TESTS ARE USED TO DIAGNOSE OSTEOMYELITIS?    DO POSITIVE CULTURES ALWAYS MEAN A BONE INFECTION IS PRESENT?   WHEN DO I NEED A NUCLEAR SCAN?

TYPES OF BONE INFECTIONS:   There are really only three etiologic categories of bone infection, not five:  hematogenous (blood-born) osteomyelitis;  contiguous-focus osteomyelitis;  and post-traumatic osteomyelitis.  Osteomyelitis due to vascular insufficiency is a form of contiguous focus infection since the lack of oxygen leads to breakdown of the integument (skin), ulceration and eventual exposure ( and contamination) of the underlying bone (a contiguous focus).  Ischemic compromise can  occur in patients with peripheral vascular disease, disruption of major bood vessels, diabetes (foot ulcers) and patients developing bed (decubitus) ulcers.

The categorization of bone infection into etiologic types,  however, does not help with establishing a treatment strategy or prognosis.  To do this, the chronology (see above), patient’s health and anatomic localization of the infection (in the bone itself) must be brought together into a staging system similar to those used for various forms of cancer.    For example, vertebral osteomyelitis is a regional localization of infection (the spine) as opposed to an anatomic localization (configuration) of the disease in the spinal bone (s) itself.  Spine infections occur following: blood-born contamination (hematogenous) to the marrow part of the bone or to the disc between the vertebral bodies;  as a contiguous focus infection (sacral decubitus ulcers); or following trauma (ie; post-operative, surgical site infections ).   Treatment will depend on the etiology, the timing (acute, subacute, chronic) and the extent to which the infection involves the bone (on the surface, in the marrow, fracture with instability, etc.).  That is why the CIERNY/MADER Clinical Staging System (1985)  is now accepted internationally as the gold standard for classifying bone infection in adults (all types, all etiologies, all locations) as it articulates the natural history of the disease with treatment and outcomes.

Next Page »

Treatment Results

!

Working in collaboration with local, national, and international facilities, the orthopedic medicine and surgery specialists at REOrthopaedics, Inc., in San Diego have spearheaded numerous scientific investigations that have led to practical treatment solutions bringing immediate benefits to patients and families throughout the world.

Learn more about our Internet Consultation.


7910 Frost Street, Suite 120
San Diego, California 92123
Google Map & Driving Directions

Phone: (858) 300-0487

Fax: (858) 300-0484